Figures & data
Figure 2. HPLC profile of FDAA derivatives of the acid hydrolysates of DKPs: (A) cyclo(D-Pro-L-Met) and (B) cyclo-(D-Pro-D-Tyr).
![Figure 2. HPLC profile of FDAA derivatives of the acid hydrolysates of DKPs: (A) cyclo(D-Pro-L-Met) and (B) cyclo-(D-Pro-D-Tyr).](/cms/asset/54e60a53-1901-4cdc-b0d5-b59605964d0d/ienz_a_765414_f0002_b.jpg)
Table 1. HPLC reversed-phase retention times of the standard L and D-amino acid and CDPs derivatives.
Figure 3. HPLC chromatogram of diketopiperazines on a reversed-phase C18 column (LC-20AD). Samples of 15 µl were injected to a column (250 mm × 4.6 mm × 5 mm), eluted with 100% methanol (A) cyclo(D-Pro-L-Met), retention time is 2.711 min. The calculated purity is 98% based on the peak area (B) cyclo-(D-Pro-D-Tyr), retention time is 2.820 min. The calculated purity is 92% based on the peak area.
![Figure 3. HPLC chromatogram of diketopiperazines on a reversed-phase C18 column (LC-20AD). Samples of 15 µl were injected to a column (250 mm × 4.6 mm × 5 mm), eluted with 100% methanol (A) cyclo(D-Pro-L-Met), retention time is 2.711 min. The calculated purity is 98% based on the peak area (B) cyclo-(D-Pro-D-Tyr), retention time is 2.820 min. The calculated purity is 92% based on the peak area.](/cms/asset/af35bceb-6199-4ab6-8327-c6f77fb942c1/ienz_a_765414_f0003_b.jpg)
Figure 4. DSC curves of diketopiperazines. Temperatures corresponding to the onset of transition and midpoint of the transition region and enthalpy (ΔH) were recorded by means of the built-in software: (A) cyclo(D-Pro-L-Met) and (B) cyclo-(D-Pro-D-Tyr).
![Figure 4. DSC curves of diketopiperazines. Temperatures corresponding to the onset of transition and midpoint of the transition region and enthalpy (ΔH) were recorded by means of the built-in software: (A) cyclo(D-Pro-L-Met) and (B) cyclo-(D-Pro-D-Tyr).](/cms/asset/16bce721-7f53-4131-a68c-bdeb1cdd213c/ienz_a_765414_f0004_b.jpg)
Table 2. NMR data for DKPs in CDCl3 (δ in ppm, J in Hz).
Table 3. MIC of diketopiperazines against test fungi.
Table 4. MIC and MBC of diketopiperazines against test bacteria.
Table 5. Antimicrobial activity of diketopiperazines.